Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 25.11.2021

United Bankers Corporation NOTIFICATION 25.11.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 25.11.2021 Date 25.11.2021Exchange transaction BuyShare class UNITEDAmount 339Average price/share 13.5000 EURHighest price/share 13.5000 EURLowest price/share 13.5000 EURTotal price 4,576.50 EUR The shares held by United Bankers Corporation on 25.11.2021: UNITED 53,589 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

Musti Group plc – Managers' transactions – Rönnberg

Musti Group plc – Managers' transactions – Rönnberg Musti Group plc            Managers’ transactions                  25 November 2021, at 6.30 p.m. Musti Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rönnberg, David Position: Chief Executive Officer Issuer: Musti Group Oyj LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 743700IE9NQGF9YZAI97_20211125123625_15 ____________________________________________ Transaction date: 2021-11-25

Terveystalo Plc: SHARE REPURCHASE 25.11.2021

Terveystalo Plc ANNOUNCEMENT  25.11.2021 Terveystalo Plc: SHARE REPURCHASE 25.11.2021 In the Helsinki Stock Exchange Trade date           25.11.2021Bourse trade         BuyShare                  TTALOAmount             28 200 SharesAverage price/ share    11,0453 EURTotal cost            311 477,46 EUR Terveystalo Plc now holds a total of 1 148 534 sharesincluding the shares repurchased on 25.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Indutrade issues a bond loan of SEK 750 million

Indutrade AB (publ) has issued a senior unsecured bond of SEK 750 million with a tenor of four years.The bond loan amounts to SEK 750 million and carries a floating interest rate of three months STIBOR +0.74%. The proceeds from the bond issue will be used for refinancing of existing loans and for general corporate purposes. The transaction generated strong investor demand. Indutrade will apply for the new bond to be listed on Nasdaq Stockholm's Corporate Bond List. Handelsbanken and Nordea acted as financial advisors in connection with the new bond issue. Stockholm, 25 November

ADDvise receives allocation decision worth approximately EUR 5 million

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Oulu University Hospital in Finland regarding a long-term partnership for delivery of x-ray equipment and services during a ten-years period, with a total value of EUR 5 million. First installations are expected to take place during the year 2023. In accordance with Finnish procurement law the allocation decision can be appealed directly to the procuring unit.  For further information, please contact:Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se Important

ODI Pharma AB: Publication of interim report for the first quarter 2021/2022

ODI Pharma AB (“ODI Pharma” or the “Company”) hereby publishes its interim report concerning the period July 2021 – September 2021. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.First quarter (2021-07-01 – 2021-09-30) The Group's net sales amounted to SEK 0 (0). The Group's loss after financial items amounted to SEK -1,175,388 (-1,268,107). Result per share amounted to SEK -0.08 (-0.08).* The solidity as of 2021-09-30 was 94 % (97 %).** * The Company’s result per share:

Financial report for the 3rd quarter 2021

· Revenues for the third quarter of 2021 was MNOK 1,500 vs MNOK 1,316 in 2020, while EBITDA adjusted for the third quarter was MNOK 500 vs MNOK 395 in 2020 · High order intake in 3Q 2021, approx. MNOK 2,000 · The offshore activity continues to gradually improve both within oil & gas and offshore-wind and new contracts have been signed at improved terms · Of the company’s core fleet, 81 of 90 vessels has been working during the quarter · Sold 24 of 37 vessels classified as non-strategic in 2021 · The Company is continuously working on upgrading its fleet to battery-hybrid to

Sandvik to acquire software provider ICAM

Sandvik has signed an agreement to acquire Canada-based ICAM Technologies Corporation, a provider of innovative solutions that translate CAM data into optimized coding for guiding CNC machining operations. With a global reach, ICAM sells to some of the world’s most renowned companies in the aerospace and defense, general engineering and automotive industries. The company will be reported in Sandvik Coromant, a division within Sandvik Manufacturing and Machining Solutions. “I am very pleased that we can welcome ICAM to Sandvik. We continue to add software companies that enable us to

#21-389 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Update on regulatory approvals relating to the voluntary tender offer for Sbanken ASA – Further extension of the Drop Dead Date

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 25 November 2021 Reference is made to the offer document dated 23 April 2021 (the "Offer Document") and subsequent stock exchange announcements, including 24 May 2021 (extension of the Offer Period until 7 June 2021), 7 June 2021 (final extension of Offer Period until 14 June 2021, reduction of minimum acceptance condition to 2/3 and

Fiven ASA third quarter report 2021

· Total revenues reported at EUR 31.8m, representing an increase of 51.9% versus Q3 2020 being significantly penalized by the Covid-19 crises. · The revenues continue to rise, and the sequential growth represents an improvement of 5.1% over Q2 2021. · The adjusted EBITDA was EUR 7.2m, versus EUR 4.5m in Q3 2020. · The adjusted EBITDA margin was 22.7%, up from 21.4% in Q3 2020.   · Last twelve months revenues at Q3 2021 showed EUR 114.2m, and adjusted EBITDA was EUR 22.2m. · The adjusted EBITDA performance in Q3 2020 was the lowest of the last year resulting from the pandemic

Vitrolife expands its Genomics business to the Asia Pacific region

Vitrolife AB (publ) today announced that it will be expanding its distribution of genomic testing kits to the Asia Pacific region (excluding China) in accordance with the Illumina partnership agreement announced in October 2018. The expansion of the territory follows the commercial launch of EmbryoMap during Q2 of this year and requires a payment of USD 3 million (approximately SEK 27 million) to Illumina for the expanded rights. EmbryoMap has been developed by Vitrolife for use on Illumina sequencing instruments. Vitrolife expects the acquired business to add more than SEK 50 million of

Nexam Chemical presents at Stora Aktiedagen Stockholm

Aktiespararna presents Stora Aktiedagen Stockholm on Tuesday the 30[th] of November. Nexam Chemical are presented by CEO Johan Arvidsson at 10.30. The presentation will also be broadcasted live via www.aktiespararna.se/tv/live and will be available afterwards on the company website and on www.aktiespararna.se/tv/evenemang.For you visiting stora aktiedagen, there is the opportunity to meet Johan Arvidsson before the presentation. After the presentation, unfortunately, the opportunity is limited. Note: This news has been translated from Swedish. The Swedish text shall govern for all

Aspire Global’s BtoBet enters Poland through partnership with BestBet24

Aspire Global's  BtoBet, a leading sportsbook provider, has signed a deal with BestBet24 which marks it entry into the Polish market. BtoBet will provide BestBet24 with its Neuron 3 sportsbook platform for both retail and online channels.Warsaw-based BestBet24’s operations will feature an extensive network of over 80 retail shops in parallel to an online and mobile offering. BtoBet will provide BestBet24’s players with a unique betting experience through an interconnected omnichannel environment. BtoBet will also supply BestBet24 with a dedicated risk management

EQT Infrastructure successfully completes the voluntary tender offer for Solarpack

· EQT Infrastructure, through Veleta BidCo, completes the voluntary tender offer for Solarpack, a geographically diversified renewable energy developer and owner of solar photovoltaic plants  · The total acceptance of the tender offer for Solarpack reaches 96.04 percent, which will allow Veleta BidCo to exercise the squeeze-out right for the Company’s remaining shares  · The delisting of Solarpack is expected to take place in the end of December 2021EQT is pleased to announce that the EQT Infrastructure V fund (“EQT Infrastructure”), through the investment vehicle Veleta BidCo S.à

Report from the Extraordinary General Meeting in DexTech Medical AB

Today, November 25, 2021, an Extraordinary General Meeting of DexTech Medical AB ("DexTech") was held. The EGM resolved to approve the rights issue decided by the Board on November 8, 2021. The Extraordinary General Meeting of DexTech decided today, November 25, 2021, in accordance with the Board's decision to increase the company's share capital by a maximum of SEK 201,426,345 through a new issue of a maximum of 4,476,141 shares at a subscription price of SEK 13 per share. The total issue amount is the maximum SEK 58 189 833. For the issue, the following conditions shall otherwise apply:

Stefano Fedel appointed Head of Sales and Marketing and member of Scania Executive Board

Stefano Fedel, currently Scania’s Regional Executive Director for Eurasia, Middle East and Africa, has been appointed Executive Vice President and Head of Sales and Marketing. He takes up the position effective immediately and will report to Christian Levin, Scania’s President and CEO.Stefano Fedel, born in 1970, joined Scania in 1996, and has a Degree in Engineering of Materials, with mechanical specialisation from Trento University. Since he started at Scania, he has held several managerial positions in services and the position as Managing Director, first for Scania Milano and later

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions         25.11.2021 at 16.15Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti ReinikkalaPosition: Member of the Board/Deputy member Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 6864/5/4____________________________________________ Transaction date: 2021-11-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of

DexTech Medical AB, Report from the Annual General Meeting

Today, November 25, 2021, the Annual General Meeting of DexTech Medical AB was held. Below is a summary of the decisions made. All decisions were made by the required majority. Decision on adoption of income statement and balance sheetThe AGM resolved to approve the presented income statement and balance sheet. Decision on dispositions regarding the company's profit according to the approved balance sheetThe AGM resolved to dispose of the company's results, and that no dividend be paid for the financial year 2020/2021. Resolution on discharge from liability for the members of

WICONA Meets Dieter Brell

” Architecture is frozen music… ” That line by German writer Johann Wolfgang von Goethe is perhaps the closest we’ll get to an enduring characterization of architecture. Throughout history, it’s been attributed the stalest of labels (“the process of constructing buildings''), or the vaguest (“social art and an artful science”) to the most philosophical: (“a dialectic between imagination and reason”).[En bild som visar person, utomhus Automatiskt genererad beskrivning] But whether you’re a pragmatist or a grand philosophe, the fact that buildings around us, like music, is a testament to the

Orkla ASA: Mandatory notification of trade – primary insider

Jaan Ivar Semlitsch, President & CEO of Orkla, has today, 25 November 2021, bought 6,500 shares in Orkla ASA at a price of NOK 85.07 per share. The shares were acquired on the Oslo Stock Exchange.Following this transaction, Semlitsch and personal related parties own 85,171 shares in Orkla ASA. For further information, see attachment available at www.newsweb.no. Orkla ASAOslo, 25 November 2021 Ref.:SVP Investor RelationsKari LindtvedtTel.: +47 950 75 114

Webstep ASA: Long-Term Incentive Program grant of share options to primary insiders

Oslo, 25 November 2021: Reference is made to the stock exchange announcement published by Webstep ASA (the "Company") earlier today, on 25 November 2021, regarding the board of directors' resolution to grant share options to certain members of the Company's executive management and other leaders in the group under the Company's long-term incentive programme.The following primary insiders of the Company have today, on 25 November 2021, been granted share options with an exercise price of NOK 36.6. Arnt Roger Aasen, Director Internal Communications and Marketing, has been granted 25,000

Report for the period 1 Jan - 30 Sep 2021

1 July – 30 September 2021 · Net sales amounted to SEK 2.84 m (2.76) · Net operating income was SEK 557,000 (-430,000) · The operating loss was SEK 13.82 m (-5.98) · The loss for the period was SEK 14.97 m (-17.48) · Earnings per share before and after dilution were SEK -29.93 (-34.96) 1 January – 30 September 2021 · Net sales amounted to SEK 8.26 m (8.25) · Net operating income was SEK -652,000 (-2.88 m) · The operating loss was SEK 32.85 m (-18.05) · The loss for the period was SEK 37.35 m (-52.88) · Earnings per share before and after dilution were

There are no items matching the current filter
There are no more items matching the current filter
Back to top